RI
PRQR icon

RTW Investments’s ProQR Therapeutics PRQR Stock Holding History

RTW Investments’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,019,610
Closed -$6.35M – 113
2022
Q1 		$6.35M Sell
7,019,610
-8,115
-0.1% -$27.2K 0.13% 72
2021
Q4 		$56.3M Buy
7,027,725
+584,612
+9% +$4.45M 0.82% 37
2021
Q3 		$53.9M Hold
6,443,113
– – 0.81% 35
2021
Q2 		$43.4M Buy
6,443,113
+19,035
+0.3% +$123K 0.66% 39
2021
Q1 		$42.5M Buy
6,424,078
+1,414,310
+28% +$7.23M 0.66% 43
2020
Q4 		$21M Buy
5,009,768
+36,594
+0.7% +$154K 0.35% 56
2020
Q3 		$23.8M Buy
4,973,174
+70,389
+1% +$368K 0.57% 43
2020
Q2 		$29.8M Buy
4,902,785
+123,650
+3% +$668K 0.84% 35
2020
Q1 		$26.2M Hold
4,779,135
– – 1.13% 31
2019
Q4 		$47.4M Buy
4,779,135
+1,078,302
+29% +$8.4M 1.79% 19
2019
Q3 		$21.3M Sell
3,700,833
-22,117
-0.6% -$177K 1.27% 23
2019
Q2 		$33.9M Hold
3,722,950
– – 1.81% 17
2019
Q1 		$51.6M Buy
3,722,950
+3,274,809
+731% +$48.9M 3.52% 6
2018
Q4 		$7.07M Sell
448,141
-3,291,265
-88% -$60.4M 0.65% 33
2018
Q3 		$72.4M Buy
+3,739,406
New +$39.7M 4.33% 6

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

RTW Investments's PRQR Position: Q2 2022 in Review

RTW Investments sold out of ProQR Therapeutics (PRQR) in Q2 2022, closing a stake of 7,019,610 shares — an estimated $6.35M sold.

RTW Investments first reported a position in PRQR in Q3 2018 and held it in 15 quarters. The position peaked at $72.4M in Q3 2018. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2022.

  • RTW Investments reported no remaining ProQR Therapeutics position as of Q2 2022 after selling out during the quarter.
  • RTW Investments sold 7,019,610 ProQR Therapeutics shares in Q2 2022, an estimated $6.35M.
  • RTW Investments first reported a position in ProQR Therapeutics in Q3 2018 and held it in 15 quarters.
  • RTW Investments's ProQR Therapeutics position peaked at $72.4M in Q3 2018.
  • 51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2022.

Based on RTW Investments's 13F filing for Q2 2022, filed 15 Aug 2022.